glp-1 fsa eligible HSA/FSA Weight Loss Medication HSA Eligible GLP-1 Medications |

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

Declining GLP-1 drug prices reveals how selling directly to consumers makes health care more affordable.

These medications belong to a class of glucagon-like peptide-1 (GLP-1) receptor agonists and are marketed under brand names such as Ozempic, Wegovy, Victoza, and Saxenda.GLP-1 is a naturally occurring hormone produced in the gut and brain that regulates appetite, blood suga

The addition of chicory inulin provides complementary prebiotic support to help nourish beneficial organisms

From the approval of Orlistat (Xenical) in 1999, which focused on reducing dietary fat absorption, to the emergence of highly effective incretin-based therapies such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), we have witnessed a fundamental shift in how obesity is understood and treated

The rapid global adoption of GLP-1 based therapies, developed for diabetes and now also used for weight management, has reshaped the pharma landscape